You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 29, 2025

Drug Price Trends for NDC 00054-0163


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00054-0163

Drug NameNDCPrice/Unit ($)UnitDate
MYCOPHENOLATE 250 MG CAPSULE 00054-0163-29 0.16587 EACH 2025-04-23
MYCOPHENOLATE 250 MG CAPSULE 00054-0163-25 0.16587 EACH 2025-04-23
MYCOPHENOLATE 250 MG CAPSULE 00054-0163-29 0.17433 EACH 2025-03-19
MYCOPHENOLATE 250 MG CAPSULE 00054-0163-25 0.17433 EACH 2025-03-19
MYCOPHENOLATE 250 MG CAPSULE 00054-0163-29 0.16665 EACH 2025-02-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 00054-0163

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
MYCOPHENOLATE MOFETIL 250MG CAP Golden State Medical Supply, Inc. 00054-0163-29 500 250.06 0.50012 2023-06-23 - 2028-06-14 FSS
MYCOPHENOLATE MOFETIL 250MG CAP Golden State Medical Supply, Inc. 00054-0163-29 500 244.10 0.48820 2023-06-15 - 2028-06-14 FSS
MYCOPHENOLATE MOFETIL 250MG CAP Golden State Medical Supply, Inc. 00054-0163-25 100 53.18 0.53180 2023-06-23 - 2028-06-14 FSS
MYCOPHENOLATE MOFETIL 250MG CAP Golden State Medical Supply, Inc. 00054-0163-25 100 51.94 0.51940 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for the Drug NDC: 00054-0319

Introduction to NDC 00054-0319

The National Drug Code (NDC) 00054-0319 corresponds to Linezolid, a pharmaceutical product used to treat various bacterial infections. Linezolid is an oxazolidinone antibiotic, available in several formulations, including a 100 mg/5 ml oral suspension.

Drug Overview

Linezolid is prescribed for infections caused by Gram-positive bacteria that are resistant to other antibiotics. It works by inhibiting protein synthesis in bacteria, thereby preventing their growth and replication.

Current Pricing Trends

To analyze the market and project prices for Linezolid (NDC 00054-0319), we need to look at recent pricing trends.

  • Recent Prices: As of the latest data, the price per unit of Linezolid 100 mg/5 ml suspension has fluctuated. For example, in December 2024, the price was $1.95344 per ml, while in November 2024, it was $1.69693 per ml. This indicates some volatility in pricing[1].

Historical Price Analysis

Analyzing historical data is crucial for understanding price trends.

  • Price Volatility: Over the past year, the price per unit has ranged from $1.69693 to $1.95344 per ml. This variability suggests that the market is subject to fluctuations, possibly due to changes in demand, supply chain issues, or regulatory factors[1].

Market Factors Influencing Prices

Several factors can influence the prices of pharmaceuticals like Linezolid.

  • Demand and Supply: Changes in demand due to outbreaks of resistant bacterial infections or supply chain disruptions can impact prices.
  • Regulatory Changes: Any changes in FDA regulations or the structure of NDC numbers, as discussed in the context of the FDA running out of NDC numbers, could have a broader impact on the pharmaceutical supply chain and pricing[5].

Price Inflation Projections

General trends in the pharmaceutical industry can also provide insights into future price projections.

  • Industry-Wide Inflation: The pharmaceutical industry is expected to see a general increase in prices due to projected inflation rates. For instance, a 3.81% drug price inflation rate is anticipated, which could affect the pricing of Linezolid as well[2].

Impact of AI and Health Tech

The increasing use of artificial intelligence (AI) and health technology in the pharmaceutical industry could also influence pricing and market dynamics.

  • AI Adoption: The adoption of AI in clinical development and data analysis is expected to increase. This could lead to more efficient drug development and potentially lower costs, but it may also introduce new costs related to AI implementation and data management[3].

External Data and Market Models

The use of external data to train internal data science models is becoming more prevalent.

  • Data-Driven Models: Pharmaceutical companies are increasingly relying on external data to improve their internal models. This trend could lead to better pricing strategies and more accurate market predictions, but it also depends on the quality of the data used[3].

Regulatory and Affordability Reviews

Regulatory bodies often review drug prices to ensure affordability and compliance with cost thresholds.

  • Affordability Thresholds: Drugs with significant price increases, such as a 15% increase in a 12-month period or a 50% cumulative increase over three years, are subject to review. While Linezolid's current price fluctuations do not indicate such drastic increases, any future significant rise could trigger regulatory scrutiny[4].

Key Takeaways

  • Current Pricing: Linezolid (NDC 00054-0319) has seen recent prices ranging from $1.69693 to $1.95344 per ml.
  • Historical Volatility: Prices have been volatile over the past year.
  • Market Factors: Demand, supply, and regulatory changes can influence prices.
  • Inflation Projections: A general 3.81% drug price inflation rate is expected.
  • AI and Health Tech: Increasing adoption of AI could impact efficiency and costs.
  • Regulatory Reviews: Significant price increases could trigger regulatory reviews.

FAQs

Q: What is the current price of Linezolid (NDC 00054-0319)? A: As of the latest data, the price per unit of Linezolid 100 mg/5 ml suspension is around $1.95344 per ml.

Q: What factors influence the price of Linezolid? A: Factors include demand and supply dynamics, regulatory changes, and general industry-wide inflation.

Q: How is AI impacting the pharmaceutical industry? A: AI is being adopted more widely in clinical development and data analysis, which could lead to more efficient processes but also introduces new costs.

Q: What regulatory changes might affect the pricing of Linezolid? A: Changes in NDC numbers and affordability reviews based on significant price increases could impact pricing.

Q: How do external data models affect pharmaceutical pricing? A: External data is used to improve internal models, potentially leading to better pricing strategies, but the quality of the data is crucial.

Sources

  1. DrugPatentWatch - Latest drug prices and trends for NDC 00054-0319.
  2. DrugPatentWatch - Latest drug prices and trends for NDC 59630-0551.
  3. Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
  4. HCA.WA.GOV - Methodology for Identifying Drugs for Affordability Review.
  5. WoltersKluwer - Are You Prepared for a Major Industry Change to the National Drug Code (NDC) Number?

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.